Lyon, F: IARC
Serious hypersensitivity reactions, including anaphylaxis and angioedema have been reported with Wegovy LIMITATIONS OF USE According to the package insert, Wegovy should not be coadministered with other semaglutide-containing products or with any GLP-1 receptor agonist safety and efficacy in combination with other products intended for weight loss, including prescription drugs, over-the-counter drugs, and herbal preparations, have not been established has not been studied in patient with a history of pancreatitis WARNINGS AND PRECAUTIONS The safety profile of semaglutide in the treatment of obesity has been investigated through several clinical trials
S., Blagojevic-Bucknall, M., Burton, C., Dziedzic, K
Insbesondere im hheren Lebensalter kommt der Skelettmuskulatur eine entscheidende Bedeutung fr den Erhalt der funktionellen Kapazitt und Selbststndigkeit zu (26)
When you take semaglutide regularly, your GLP-1 receptorsthe cellular targets where the medication docksgradually become less sensitive to the same signal over time
